OncoGenex Pharmaceuticals Inc. (ACHV) Sets New 1-Year Low at $2.02

OncoGenex Pharmaceuticals Inc. (NASDAQ:ACHV) reached a new 52-week low during trading on Tuesday . The stock traded as low as $2.02 and last traded at $2.02, with a volume of 20,062 shares changing hands. The stock had previously closed at $2.04.

Separately, ValuEngine upgraded OncoGenex Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Friday, August 4th.

The company’s market capitalization is $21.89 million. The stock has a 50 day moving average of $2.65 and a 200 day moving average of $3.77.

OncoGenex Pharmaceuticals (NASDAQ:ACHV) last posted its quarterly earnings data on Monday, July 31st. The biopharmaceutical company reported ($0.10) earnings per share for the quarter.

WARNING: “OncoGenex Pharmaceuticals Inc. (ACHV) Sets New 1-Year Low at $2.02” was first published by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2017/10/12/oncogenex-pharmaceuticals-inc-achv-sets-new-1-year-low-at-2-02.html.

About OncoGenex Pharmaceuticals

Achieve Life Sciences, Inc, formerly OncoGenex Pharmaceuticals, Inc, is a clinical-stage biopharmaceutical company engaged in the development and commercialization of therapies that address treatment resistance in cancer patients. The Company’s segment is dedicated to the development and commercialization of cancer therapies, with operations located in Canada and the United States.

Receive News & Ratings for OncoGenex Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoGenex Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply